SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
- PMID: 32196087
- PMCID: PMC7184407
- DOI: 10.1093/eurheartj/ehaa235
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Figures
Comment in
-
Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.Eur Heart J. 2020 Jun 7;41(22):2126-2127. doi: 10.1093/eurheartj/ehaa423. Eur Heart J. 2020. PMID: 32432704 Free PMC article. No abstract available.
Similar articles
-
SARS-CoV2 and pregnancy: An invisible enemy?Am J Reprod Immunol. 2020 Nov;84(5):e13308. doi: 10.1111/aji.13308. Epub 2020 Aug 1. Am J Reprod Immunol. 2020. PMID: 32678975 Free PMC article. Review.
-
Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.J Physiol Pharmacol. 2020 Apr;71(2). doi: 10.26402/jpp.2020.2.01. Epub 2020 Jul 2. J Physiol Pharmacol. 2020. PMID: 32633235 Review.
-
The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene.Immune Netw. 2020 Oct 26;20(5):e41. doi: 10.4110/in.2020.20.e41. eCollection 2020 Oct. Immune Netw. 2020. PMID: 33163249 Free PMC article.
-
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.Hypertension. 2020 Sep;76(3):742-749. doi: 10.1161/HYPERTENSIONAHA.120.15464. Epub 2020 Jul 13. Hypertension. 2020. PMID: 32654557
-
Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?Eur J Pharmacol. 2020 Sep 15;883:173373. doi: 10.1016/j.ejphar.2020.173373. Epub 2020 Jul 15. Eur J Pharmacol. 2020. PMID: 32679185 Free PMC article.
Cited by
-
Exercise Training in Patients with Heart Failure: From Pathophysiology to Exercise Prescription.Rev Cardiovasc Med. 2022 Apr 12;23(4):144. doi: 10.31083/j.rcm2304144. eCollection 2022 Apr. Rev Cardiovasc Med. 2022. PMID: 39076241 Free PMC article. Review.
-
ACE I/D polymorphism is a risk factor for the clinical severity of COVID-19 in Brazilian male patients.Mol Biol Rep. 2024 Jan 22;51(1):180. doi: 10.1007/s11033-023-09189-4. Mol Biol Rep. 2024. PMID: 38252233
-
[Influence of the Corona pandemic on cardiovascular risk factors - Data from 1775 participants of the ELITE study before and during the Corona pandemic].Dtsch Med Wochenschr. 2024 Feb;149(3):e11-e18. doi: 10.1055/a-2201-6772. Epub 2023 Nov 23. Dtsch Med Wochenschr. 2024. PMID: 37995721 Free PMC article. German.
-
Phenome-wide association study and precision medicine of cardiovascular diseases in the post-COVID-19 era.Acta Pharmacol Sin. 2023 Dec;44(12):2347-2357. doi: 10.1038/s41401-023-01119-1. Epub 2023 Aug 2. Acta Pharmacol Sin. 2023. PMID: 37532784 Review.
-
Association between echocardiographic features and inflammatory biomarkers with clinical outcomes in COVID-19 patients in Saudi Arabia.Front Cardiovasc Med. 2023 May 26;10:1134601. doi: 10.3389/fcvm.2023.1134601. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37304946 Free PMC article.
References
-
- Sommerstein R, Gräni C.. Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19. BMJ 2020. https://www.bmj.com/content/368/bmj.m810/rr-2 (8 March 2020).
-
- Dong E, Du H, Gardner L.. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020. https://coronavirus.jhu.edu/map.html (11 March 2020). - PMC - PubMed
-
- Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. Epub ahead of print. - PMC - PubMed
-
- Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020. Epub ahead of print. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous